Palagan Senopati Sewoyo
@unud.ac.id
Faculty of Veterinary Medicine
Udayana University
Palagan Senopati Sewoyo is assistant lecture in veterinary pathology at Faculty of Veterinary Medicine, Udayana University. He has a keen interest in veterinary pathology research. In addition to preclinical studies, he is also passionate about veterinary clinical medicine, particularly companion animal medicine and its pathology, infectious diseases and cytology.
EDUCATION
Bachelor of Veterinary Medicine (2017-2021)
Doctor of Veterinary Medicine (2021-2023)
Master of Veterinary Science (2022-2024)
RESEARCH, TEACHING, or OTHER INTERESTS
Veterinary, Small Animals
Scopus Publications
Scholar Citations
Scholar h-index
Scholar i10-index
Scopus Publications
Palagan Senopati Sewoyo, Anak Agung Ayu Mirah Adi, Ida Bagus Oka Winaya, and I Wayan Wirata
Universitas Airlangga
A particular type of tumor that is frequently detected in female dogs who are sexually active is a mammary tumor. Neoplasia results from DNA-based alterations in cell cycle regulating genes. The mammary gland is prone to the formation of tumors due to its dynamic structure. The development of this tumor is supported by numerous variables. It has been recently discovered that there is substantial evidence linking the BRCA2 gene to the process of cancer. Standard examination techniques, such as fine needle aspiration, histopathology, and immunohistochemistry, are used along with ancillary tests to determine the tumor type and degree of malignancy. The primary treatment option for malignant tumors is surgical resection followed by adjuvant chemotherapy; benign tumors necessitate surgical resection as well. Adjuvant therapy options include hormone therapy and non-steroidal anti-inflammatory medications. Tumor tissue undergoes angiogenesis as it grows and develops to accommodate the abundant supply of nutrients. Therefore, angiogenesis-inhibiting therapies can be utilized to halt the growth of tumor cells. A number of antiangiogenic medications are now being studied in clinical settings on humans, and several more are undergoing trials on animals. In addition to pharmaceuticals, viruses may be used as a therapeutic to block tumor angiogenesis.